Surgical Oncology
Volume 19, Issue 1 , Pages 4-10 , March 2010

Prognostic role of lymphatic vessel invasion in early gastric cancer: A retrospective study of 188 cases

,Accepted 28 October 2008.

References 

  1. Adchi Y, Shiraishi N, Kitano S. Modern treatment of early gastric cancer: review of the Japanese experience. Dig Surg. 2002;19:333–339
  2. Shimoyama S, Seto Y, Yasuda H, et al. Concepts, rationale, and current outcomes of less invasive surgical strategies for early gastric cancer: date from a quarter-century of experience in a single institution. World J Surg. 2005;29:58–65
  3. Yoshikawa T, Tsuburaya A, Kobayashi O, et al. Is D2 lymph node dissection necessary for early gastric cancer?. Ann Surg Oncol. 2002;9:401–405
  4. Hyung WJ, Cheong JH, Kim J, et al. Application of minimally invasive treatment for early gastric cancer. J Surg Oncol. 2004;85:181–185
  5. Kume K, Yamasaki M, Tashiro M, et al. Endoscopic mucosal resection for early gastric cancer: comparison of two modifications of the cap method. Endoscopy. 2008;40:280–283
  6. Hosono S, Ohtani H, Arimoto Y, et al. Endoscopic stenting versus surgical gastroenterostomy for palliation of malignant gastroduodenal obstruction: a meta-analysis. J Gastroenterol. 2007;42:283–290
  7. Nomura S, Kaminishi M. Surgical treatment of early gastric cancer. Dig Surg. 2007;96:35–40
  8. Japanese Gastric Cancer Association . Japanese classification of gastric carcinoma. 2nd English ed. Gastric Cancer. 1998;1:10–24
  9. International Union Against Cancer . In:  Sobin LH,  Wittekind CH editor. TNM classification of malignant tumors. 5th ed. New York: Wiley; 1997;
  10. Park YD, Chung YJ, Chung HY, et al. Factors related to lymph node metastasis and the feasibility of endoscopic mucosal resection for treating poorly differentiated adenocarcinoma of the stomach. Endoscopy. 2008;40:7–10
  11. Okabayashi T, Kobayashi M, Nishimori I, et al. Clinicopathological features and medical management of early gastric cancer. Am J Surg. 2008;195:229–232
  12. Hyung WJ, Cheong JH, Kim J, et al. Application of minimally invasive treatment for early gastric cancer. J Surg Oncol. 2004;85:181–185discussion 186
  13. Yokota T, Kunii Y, Teshima S, et al. Significant prognostic factors in patients with node-negative gastric cancer. Int Surg. 1999;84:331–336
  14. Ono H, Hasuike N, Inui T, et al. Usefulness of a novel electrosurgical knife, the insulation-tipped diathermic knife-2, for endoscopic submucosal dissection of early gastric cancer. Gastric Cancer. 2008;11:47–52
  15. Takizawa K, Oda I, Gotoda T, et al. Routine coagulation of visible vessels may prevent delayed bleeding after endoscopic submucosal dissection—an analysis of risk factors. Endoscopy. 2008;40:179–183
  16. Ming SC. Gastric carcinoma: a pathological classification. Cancer. 1977;39:2475
  17. Yokota T, Ishiyama S, Saito T, et al. Treatment strategy of limited surgery in the treatment guidelines for gastric cancer in Japan. Lancet Oncol. 2003;4:423–428
  18. Kim JP, Hur YS, Yang HK. Lymph node metastasis as a significant prognostic factor in early gastric cancer: analysis of 1,136 early gastric cancers. Ann Surg Oncol. 1995;2:308–313
  19. Yokota T, Ishiyama S, Saito T, et al. Lymph node metastasis as a significant prognostic factor in gastric cancer: a multiple logistic regression analysis. Scand J Gastroenterol. 2004;39:380–384
  20. Ichikura T, Tomimatsu S, Okusa Y, et al. Comparison of the prognostic significance between the number of metastatic lymph nodes and nodal stage based on their location in patients with gastric cancer. J Clin Oncol. 1993;11:1894–1900
  21. Hyung WJ, Lee JH, Choi SH, et al. Prognostic impact of lymphatic and/or blood vessel invasion in patients with node-negative advanced gastric cancer. Ann Surg Oncol. 2002;9:562–567
  22. Wu YF, Xu HM, Chen JQ. Relations of proliferative activities of gastric carcinoma cells to lymphatic involvement, venous invasion and prognosis. Chin Med J (Enl). 2004;117:1530–1535
  23. Greene FL, Page DL, Fleming ID, et al. AJCC Cancer Staging Manual. 6th ed.. New York: Springer; 2002;
  24. Park DJ, Kong SH, Lee HJ, et al. Subclassification of pT2 gastric adenocarcinoma according to depth of invasion (pT2a vs PT2b) and lymph node status (pN). Surgery. 2007;141:757–763
  25. Sarela AI, Turnbull AD, Coit DG, et al. Accurate lymph node staging is of greater prognostic importance than subclassification of the T2 category for gastric adenocarcinoma. Ann Surg Oncol. 2003;10:783–791
  26. Sasaki T. In regard to gastric cancer treatment guidelines—a revised edition. Gan To Kagaku Ryoho. 2004;31:1947–1951
  27. Ohtsu A. Chemotherapy for metastatic gastric cancer: past, present, and future. J Gastroenterol. 2008;43:256–264
  28. Sugarbaker PH. Laboratory and clinical basis for hyperthermia as a component of intracavitary chemotherapy. Int J Hyperthermia. 2007;23:431–442
  29. Ng K, Meyerhardt JA, Fuchs CS. Adjuvant and neoadjuvant approaches in gastric cancer. Cancer J. 2007;13:168–174
  30. Demetri GD, Benjamin RS, Blanke CD, et al. NCCN Task Force. NCCN Task Force report: management of patients with gastrointestinal stromal tumor (GIST)—update of the NCCN clinical practice guidelines. J Natl Compr Canc Netw. 2007;5(Suppl 2):S1–S29quiz S30
  31. Kim JJ, Song KY, Hur H, et al. Lymph node micrometastasis in node negative early gastric cancer. Eur J Surg Oncol. 2008 Jun 21;[Epub ahead of print]

PII: S0960-7404(08)00104-7

doi: 10.1016/j.suronc.2008.10.003

Surgical Oncology
Volume 19, Issue 1 , Pages 4-10 , March 2010

Article Tools

* Image Usage & Resolution